BGS vs. MED, THS, JBSS, SENEA, CVGW, LWAY, HAIN, FARM, MDLZ, and HSY
Should you be buying B&G Foods stock or one of its competitors? The main competitors of B&G Foods include Medifast (MED), TreeHouse Foods (THS), John B. Sanfilippo & Son (JBSS), Seneca Foods (SENEA), Calavo Growers (CVGW), Lifeway Foods (LWAY), The Hain Celestial Group (HAIN), Farmer Brothers (FARM), Mondelez International (MDLZ), and Hershey (HSY).
B&G Foods vs. Its Competitors
B&G Foods (NYSE:BGS) and Medifast (NYSE:MED) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.
In the previous week, Medifast had 5 more articles in the media than B&G Foods. MarketBeat recorded 7 mentions for Medifast and 2 mentions for B&G Foods. Medifast's average media sentiment score of 0.60 beat B&G Foods' score of 0.48 indicating that Medifast is being referred to more favorably in the news media.
Medifast has a net margin of -1.29% compared to B&G Foods' net margin of -11.16%. B&G Foods' return on equity of 7.00% beat Medifast's return on equity.
Medifast has lower revenue, but higher earnings than B&G Foods. Medifast is trading at a lower price-to-earnings ratio than B&G Foods, indicating that it is currently the more affordable of the two stocks.
B&G Foods has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Comparatively, Medifast has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500.
B&G Foods currently has a consensus target price of $7.30, indicating a potential upside of 75.27%. Medifast has a consensus target price of $16.50, indicating a potential upside of 10.26%. Given B&G Foods' higher possible upside, equities research analysts plainly believe B&G Foods is more favorable than Medifast.
66.2% of B&G Foods shares are held by institutional investors. Comparatively, 95.5% of Medifast shares are held by institutional investors. 4.0% of B&G Foods shares are held by insiders. Comparatively, 2.9% of Medifast shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
Medifast beats B&G Foods on 10 of the 15 factors compared between the two stocks.
Get B&G Foods News Delivered to You Automatically
Sign up to receive the latest news and ratings for BGS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BGS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
B&G Foods Competitors List
Related Companies and Tools
This page (NYSE:BGS) was last updated on 7/9/2025 by MarketBeat.com Staff
